Cargando…
Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease
BACKGROUND: Guanxin V (GXV), a traditional Chinese medicine (TCM), has been widely used to treat coronary artery disease (CAD) in clinical practice in China. However, research on the active components and underlying mechanisms of GXV in CAD is still scarce. METHODS: A virtual screening and network p...
Autores principales: | Liang, Bo, Zhang, Xiao-Xiao, Gu, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664106/ https://www.ncbi.nlm.nih.gov/pubmed/33187508 http://dx.doi.org/10.1186/s12906-020-03133-w |
Ejemplares similares
-
Guanxin V Acts as an Antioxidant in Ventricular Remodeling
por: Liang, Bo, et al.
Publicado: (2022) -
Effect of Guanxin V in animal model of acute myocardial infarction
por: Zhang, Xiaoxiao, et al.
Publicado: (2021) -
Molecular targets and mechanisms of Guanxinning tablet in treating atherosclerosis: Network pharmacology and molecular docking analysis
por: Niu, Chaofeng, et al.
Publicado: (2023) -
Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish
por: Li, Jun, et al.
Publicado: (2021) -
Study of the Mechanism of Action of Guanxin Shutong Capsules in the Treatment of Coronary Heart Disease Based on Metabolomics
por: Wang, Dan, et al.
Publicado: (2021)